Successful treatment of diffuse large b-cell lympoma following waldenström's macroglobulinemia with CHOP chemotherapy followed by combination therapy of CHOP with rituximab

Internal Medicine

Volumn 43, Issue 2, 2004, Pages 131-134

  Uchino, Keita ^a   Sameshima, Hidekazu ^a   Miyamoto, Toshihiro ^a   Iino, Tadafumi ^a   Kato, Koji ^a   Henzan, Hideho ^a   Aoki, Ken Ichi ^a   Nagafuji, Koji ^a   Gondo, Hisashi ^a   Harada, Mine ^a  

^a KYUSHU UNIVERSITY   (Japan)

Author keywords

CHOP; Diffuse large B cell lymphoma; Macroglobulinemia; Rituximab

Indexed keywords

CD19 ANTIGEN; CD20 ANTIGEN; CD38 ANTIGEN; CYCLOPHOSPHAMIDE; DOXORUBICIN; HLA DR ANTIGEN; IMMUNOGLOBULIN HEAVY CHAIN; IMMUNOGLOBULIN M; PREDNISOLONE; RITUXIMAB; VINCRISTINE;

AGED; ANTIGEN EXPRESSION; ARTICLE; B CELL LYMPHOMA; BONE MARROW BIOPSY; CANCER CELL; CANCER COMBINATION CHEMOTHERAPY; CANCER SURVIVAL; CASE REPORT; CELL SURFACE; COMPUTER ASSISTED TOMOGRAPHY; DNA EXTRACTION; DRUG EFFICACY; GENE AMPLIFICATION; GENE REARRANGEMENT; HUMAN; IMMUNOHISTOCHEMISTRY; MALE; NEEDLE BIOPSY; PLASMAPHERESIS; POLYMERASE CHAIN REACTION; TREATMENT OUTCOME; WALDENSTROEM MACROGLOBULINEMIA;

ANTIBODIES, MONOCLONAL; ANTINEOPLASTIC AGENTS; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BONE MARROW; CYCLOPHOSPHAMIDE; DOXORUBICIN; DRUG THERAPY, COMBINATION; HUMANS; LYMPHOMA, B-CELL; LYMPHOMA, LARGE-CELL, DIFFUSE; MALE; MIDDLE AGED; PREDNISOLONE; RETROPERITONEAL NEOPLASMS; TOMOGRAPHY, X-RAY COMPUTED; VINCRISTINE; WALDENSTROM MACROGLOBULINEMIA;

EID: 12144290294     PISSN: 09182918     EISSN: None     Source Type: Journal    
DOI: 10.2169/internalmedicine.43.131     Document Type: Article

References (17)

1. Garcia R, Hernandez JM, Caballero MD, Gonzalez M, San Miguel JF. Immunoblastic lymphoma and associated non-lymphoid malignancies following two cases of Waldenstrom's macroglobulinemia. A review of the literature. Eur J Haematol 50: 299-301, 1993.
2. Maloney DG, Grillo-Lopez AJ, White CA, et al. IDEC-C2B8 (Rituximab) anti-CD20 monoclonal antibody therapy in patients with relapsed low-grade non-Hodgkin's lymphoma. Blood 90: 2188-2195, 1997.
3. Dimopoulos MA, Zervas C, Zomas A, et al. Treatment of Waldenstrom's macroglobulinemia with rituximab. J Clin Oncol 20: 2327-2333, 2002.
4. A predictive model for aggressive non-Hodgkin's lymphoma. The International Non-Hodgkin's Lymphoma Prognostic Factors Project. N Engl J Med 329: 987-994, 1993.
5. Cheson BD, Horning SJ, Coiffier B, et al. Report of an international workshop to standardize response criteria for non-Hodgkin's lymphomas. NCI Sponsored International Working Group. J Clin Oncol 17: 1244-1253, 1999 (Published erratum in J Clin Oncol 18: 2351, 2000).
6. Harousseau JL, Flandrin G, Tricot G, Brouet JC, Seligmann M, Bernard J. Malignant lymphoma supervening in chronic lymphocytic leukemia and related disorders. Richter's syndrome: a study of 25 cases. Cancer 48: 1302-1308, 1981.
7. Chubachi A, Ohtani H, Sakuyama M, et al. Diffuse large cell lymphoma occurring in a patient with Waldenstrom's macroglobulinemia. Evidence for the two different clones in Richter's syndrome. Cancer 68: 781-785, 1991.
8. Diebold J, Molina T, Tissier F, le Tourneau A, Audouin J. Waldenstrom's macroglobulinemia is a biological syndrome which may occur during the evolution of different types of low grade B cell lymphoma. Leukemia 13: 1637-1638, 1999.
9. Marinella MA, Kim MH, Anderson MM. Waldenstrom's macroglobulinemia transformed into immunoblastic lymphoma presenting with malignant ascites. Am J Hematol 51: 249-250, 1996.
10. Kogawa K, Sato T, Inohara T, et al. Waldenstrom macroglobulinemia with diffuse large B-cell lymphoma that developed from a different B-cell clone. Rinsho Ketsueki 40: 1116-1123, 1999 (in Japanese).
11. Kyrtsonis MC, Vassilakopoulos TP, Angelopoulou MK, et al. Waldenstrom's macroglobulinemia: clinical course and prognostic factors in 60 patients. Experience from a single hematology unit. Ann Hematol 80: 722-727, 2001 (Published erratum in Ann Hematol 81: 124, 2002).
12. Garcia-Sanz R, Montoto S, Torrequebrada A, et al. Waldenstrom macroglobulinaemia: presenting features and outcome in a series with 217 cases. Br J Haematol 115: 575-582, 2001.
13. Gertz MA. Waldenstrom's macroglobulinemia: a review of therapy. Leuk Lymphoma 43: 1517-1526, 2002.
14. Richter MN. Generalized reticular cell sarcoma of lymph nodes associated with lymphatic leukemia. Am J Pathol 4: 285-292, 1928.
15. Coiffier B, Lepage E, Briere J, et al. CHOP chemotherapy plus rituximab compared with CHOP alone in elderly patients with diffuse large-B-cell lymphoma. N Engl J Med 346: 235-242, 2002.
16. Yang H, Rosove MH, Figlin RA. Tumor lysis syndrome occurring after the administration of rituximab in lymphoproliferative disorders: high-grade non-Hodgkin's lymphoma and chronic lymphocytic leukemia. Am J Hematol 62: 247-250, 1999.
17. Gertz MA, Anagnostopoulos A, Anderson K, et al. Treatment recommendations in Waldenstrom's macroglobulinemia: consensus panel recommendations from the Second International Workshop on Waldenstrom's Macroglobulinemia. Semin Oncol 30: 121-126, 2003.